1 Russell 2000 Stock to Consider Right Now and 2 We Brush Off

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Navigating this part of the market can be tricky, which is why we built StockStory to help you separate the winners from the laggards. Keeping that in mind, here is one Russell 2000 stock that could deliver strong gains and two that may struggle to keep up.

Two Stocks to Sell:

TEGNA (TGNA)

Market Cap: $3.38 billion

Spun out of Gannett in 2015, TEGNA (NYSE:TGNA) is a media company operating a network of television stations and digital platforms, focusing on local news and community content.

Why Should You Dump TGNA?

1. Products and services aren't resonating with the market as its revenue declined by 2.5% annually over the last two years
2. Sales are expected to decline once again over the next 12 months as it continues working through a challenging demand environment
3. Projected 4.5 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position

TEGNA’s stock price of $21.01 implies a valuation ratio of 11.3x forward P/E. To fully understand why you should be careful with TGNA, check out our full research report (it’s free).

Privia Health (PRVA)

Market Cap: $2.81 billion

Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ:PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models.

Why Does PRVA Worry Us?

1. Modest revenue base of $1.9 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
2. Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 4.3% for the last five years
3. Negative returns on capital show management lost money while trying to expand the business

At $23 per share, Privia Health trades at 25.9x forward P/E. If you’re considering PRVA for your portfolio, see our FREE research report to learn more.

One Stock to Watch:

IMAX (IMAX)

Market Cap: $1.76 billion

Originally developed for World Expo '67 in Montreal as an innovative projection system, IMAX (NYSE:IMAX) provides proprietary large-format cinema technology and systems that deliver immersive movie experiences with enhanced image quality and sound.

Why Does IMAX Stand Out?

1. Performance over the past two years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 34.3% outpaced its revenue gains
2. Free cash flow margin grew by 26.4 percentage points over the last five years, giving the company more chips to play with
3. Returns on capital are increasing as management’s prior bets are starting to bear fruit

IMAX is trading at $32.66 per share, or 25.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.